Capricor Therapeutics, Inc. CAPR 深 沪
已收盘 11-13 16:00:00 美东时间
9.53
-0.710
-6.93%
华盛通- 最 高10.22
- 今 开10.21
- 成交量 366.49万股
- 最 低 9.255
- 昨 收 10.24
- 总市值 5.54亿
- 52周最高 40.37
- 市盈率 静 --
- 换手率 6.30%
- 52周最低 2.96
- 委 比 -85.60%
- 总股本 5814.21万
- 历史最高 171.50
- 量 比 0.64
- 振 幅 9.42%
- 历史最低 0.50
- 每 手 1
- 风险率 10.38%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股前瞻 | 特朗普称不需要与伊朗达成协议，油价拉升，纳指期货跌1.5%；黄仁勋陷罢免危机！英伟达盘前跌超8%，竞对AMD涨超2%
特朗普称不需要与伊朗达成协议，油价拉升，纳指期货跌1.5%；黄仁勋陷罢免危机！英伟达盘前跌超8%，竞对AMD涨超2%；Anthropic首日散户净买入料达SpaceX纪录两倍；应用材料、Cerebras盘后放榜>>
11-12 21:18
美股大行评级 | Stifel等多家大行上调CoreWeave目标价；杰富瑞首予康宁"买入"评级
今日重点评级关注：韦德布什：维持Cullinan Therapeutics"跑赢大市"评级，目标价从42美元升至44美元；HC Wainwright & Co.：维持WhiteFiber"买入"评级，目标价从34美元升至36美元
11-12 19:19
美股牛股 | CoreWeave绩后飙升近25%，Q3营收暴增168%；Capricor涨逾26%，新药审批临近
CoreWeave绩后飙升近25%，Q3营收暴增168%；Capricor涨逾26%，新药审批临近
11-12 08:46
Jones Trading Upgrades Capricor Therapeutics to Buy, Announces $25 Price Target
Jones Trading analyst Catherine Novack upgrades Capricor Therapeutics (NASDAQ:CAPR) from Hold to Buy and announces $25 price target.
11-12 04:46
Capricor Stock Rises Despite Wider-Than-Expected Q3 Loss
Capricor Therapeutics Inc. (NASDAQ:CAPR) shares are trading higher Wednesday despite the company missing earnings per share estimates in its third-quarter results Tuesday after the market closed. Capricor Therapeutics stock is charging ahead with explosive momentum. What’s behind CAPR gains? Caprico...
11-11 23:31
Capricor Therapeutics Q3 2026 Earnings Call Transcript
Capricor Therapeutics (NASDAQ:CAPR) held its third-quarter earnings conference call on Tuesday. Below is the complete transcript from the call. This transcript is brought to you by Benzinga APIs. For real-time access to our entire catalog, please visit https://www.benzinga.com/apis/ for a consultati...
11-11 06:12
Capricor Therapeutics to Report Third Quarter 2026 Financial Results and Provide Recent Corporate Update on November 10
Capricor Therapeutics (NASDAQ: CAPR) announced it will release its third-quarter 2026 financial results on November 10, 2026, after market close, followed by a conference call and webcast at 4:30 p.m. ET. The call will include toll-free and international dial-in numbers, a conference ID, and webcast access. A replay will be available on the company’s website. Capricor focuses on developing cell and exosome-based therapeutics for rare diseases, wi...
11-03 14:00
期权扫描 | 存储股逆势回升！美光科技多张Call单升逾200%；亚马逊获逾7成Call看多，押注短线站上260美元
存储股逆势回升！美光科技多张Call单升逾200%，投行唱多股价至3000美元；亚马逊获逾7成Call看多，押注短线站上260美元>>
10-08 19:30
Short Interest Alert: Most and least shorted sub-$2B healthcare stocks in Sep. 2026
Short interest data from late September 2026 highlights deeply divided investor sentiment across small-cap healthcare stocks (market capitalizations up to $2B). Heavy bearish bets remain concentrated ...
10-02 22:15
Capricor Therapeutics Stock Surges: What's Going On?
Shares of Capricor Therapeutics Inc. (NASDAQ:CAPR) are trading higher Wednesday morning following the release of positive long-term clinical data for its lead cellular therapy. The rally provides critical support for the biotechnology firm as it attempts to salvage a regulatory approval following a ...
09-30 23:18
